Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products. An InPharma commentary

Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
European Journal of Pharmaceutical Sciences
Special issue
DOI of the original publication
Link
Series
Series number
Volume
188
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Elsevier
Place of publication / Event location
Edition
Version
Programming language
Assignee
Practice partner / Client
Keywords
Project
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
0928-0987
1879-0720
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
Peer review of the complete publication
Open access category
Gold
License
'https://creativecommons.org/licenses/by/4.0/'
Citation
Reppas, C., Kuentz, M., Bauer-Brandl, A., Carlert, S., Dallmann, A., Dietrich, S., Dressman, J., Ejskjaer, L., Frechen, S., Guidetti, M., Holm, R., Holzem, F. L., Karlsson, Ε., Kostewicz, E., Panbachi, S., Paulus, F., Senniksen, M. B., Stillhart, C., Turner, D. B., et al. (2023). Leveraging the use of in vitro and computational methods to support the development of enabling oral drug products. An InPharma commentary. European Journal of Pharmaceutical Sciences, 188. https://doi.org/10.1016/j.ejps.2023.106505